Marico Limited — Important, 31-01-2025: Financial Result Updates

Marico Limited's consolidated financial results for the quarter ended December 31, 2024, reveal a revenue of ₹2,794 crore, representing a growth of 15.4% year-over-year, driven by strong demand for its health-focused products and strategic market expansions. Net profit for the quarter stands at ₹406 crore, up from ₹386 crore in the same period last year, yielding an Earnings Per Share (EPS) of ₹3.08, indicative of robust profitability amid rising costs.

Total expenses increased to ₹2,318 crore, largely due to higher raw material costs (₹1,283 crore, up 41% YoY) and advertising expenses (₹293 crore, up 19%), reflecting the company's aggressive marketing approach. However, operational cost management remains a critical focus following margin pressures.

The balance sheet reflects a positive cash flow position, with effective debt management ensuring financial stability. Strategic initiatives are aimed at leveraging growth through innovation and optimizing supply chain efficiencies.

Investor sentiment appears optimistic, calling for a hold stance amid short-term pressures but considering long-term growth potential stemming from brand strength and market leadership. The declared interim dividend of ₹3.50 per equity share further suggests confidence in future earnings.